vs

Side-by-side financial comparison of Comstock Holding Companies, Inc. (CHCI) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

Comstock Holding Companies, Inc. is the larger business by last-quarter revenue ($23.9M vs $13.2M, roughly 1.8× TriSalus Life Sciences, Inc.). Comstock Holding Companies, Inc. runs the higher net margin — 56.3% vs -73.9%, a 130.2% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 41.5%). Over the past eight quarters, Comstock Holding Companies, Inc.'s revenue compounded faster (50.0% CAGR vs 43.0%).

The Comstock Lode is a lode of silver ore located under the eastern slope of Mount Davidson, a peak in the Virginia Range in Virginia City, Nevada, which was the first major discovery of silver ore in the United States and named after Canadian miner Henry Comstock.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

CHCI vs TLSI — Head-to-Head

Bigger by revenue
CHCI
CHCI
1.8× larger
CHCI
$23.9M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+18.3% gap
TLSI
59.8%
41.5%
CHCI
Higher net margin
CHCI
CHCI
130.2% more per $
CHCI
56.3%
-73.9%
TLSI
Faster 2-yr revenue CAGR
CHCI
CHCI
Annualised
CHCI
50.0%
43.0%
TLSI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHCI
CHCI
TLSI
TLSI
Revenue
$23.9M
$13.2M
Net Profit
$13.5M
$-9.8M
Gross Margin
35.5%
86.7%
Operating Margin
32.4%
-24.8%
Net Margin
56.3%
-73.9%
Revenue YoY
41.5%
59.8%
Net Profit YoY
30.5%
3.5%
EPS (diluted)
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCI
CHCI
TLSI
TLSI
Q4 25
$23.9M
$13.2M
Q3 25
$13.3M
$11.6M
Q2 25
$13.0M
$11.2M
Q1 25
$12.6M
$9.2M
Q4 24
$16.9M
$8.3M
Q3 24
$13.0M
$7.3M
Q2 24
$10.8M
$7.4M
Q1 24
$10.6M
$6.5M
Net Profit
CHCI
CHCI
TLSI
TLSI
Q4 25
$13.5M
$-9.8M
Q3 25
$541.0K
$-10.8M
Q2 25
$1.4M
$-8.3M
Q1 25
$1.6M
$-10.4M
Q4 24
$10.3M
$-10.1M
Q3 24
$2.4M
$-2.4M
Q2 24
$946.0K
$-4.3M
Q1 24
$910.0K
$-13.2M
Gross Margin
CHCI
CHCI
TLSI
TLSI
Q4 25
35.5%
86.7%
Q3 25
11.0%
83.5%
Q2 25
19.0%
83.9%
Q1 25
18.6%
83.7%
Q4 24
33.4%
85.3%
Q3 24
26.3%
86.3%
Q2 24
17.2%
87.6%
Q1 24
16.5%
85.0%
Operating Margin
CHCI
CHCI
TLSI
TLSI
Q4 25
32.4%
-24.8%
Q3 25
5.0%
-77.9%
Q2 25
13.7%
-65.4%
Q1 25
13.7%
-79.9%
Q4 24
30.1%
-91.8%
Q3 24
21.8%
-118.9%
Q2 24
11.4%
-111.0%
Q1 24
10.8%
-180.8%
Net Margin
CHCI
CHCI
TLSI
TLSI
Q4 25
56.3%
-73.9%
Q3 25
4.1%
-93.5%
Q2 25
11.1%
-73.9%
Q1 25
12.6%
-113.2%
Q4 24
61.1%
-122.4%
Q3 24
18.3%
-32.6%
Q2 24
8.8%
-58.8%
Q1 24
8.6%
-204.5%
EPS (diluted)
CHCI
CHCI
TLSI
TLSI
Q4 25
$-0.22
Q3 25
$-0.96
Q2 25
$-0.27
Q1 25
$-0.39
Q4 24
$-0.38
Q3 24
$-0.12
Q2 24
$-0.21
Q1 24
$0.09
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCI
CHCI
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$31.3M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$70.0M
$-33.9M
Total Assets
$85.0M
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCI
CHCI
TLSI
TLSI
Q4 25
$31.3M
$20.4M
Q3 25
$26.2M
$22.7M
Q2 25
$30.5M
$26.5M
Q1 25
$28.3M
$13.0M
Q4 24
$28.8M
$8.5M
Q3 24
$21.1M
$11.3M
Q2 24
$17.4M
$16.5M
Q1 24
$16.2M
$4.0M
Stockholders' Equity
CHCI
CHCI
TLSI
TLSI
Q4 25
$70.0M
$-33.9M
Q3 25
$56.3M
$-26.7M
Q2 25
$55.5M
$-19.4M
Q1 25
$53.7M
$-34.4M
Q4 24
$52.4M
$-25.9M
Q3 24
$41.7M
$-20.4M
Q2 24
$39.2M
$-25.3M
Q1 24
$37.9M
$-36.0M
Total Assets
CHCI
CHCI
TLSI
TLSI
Q4 25
$85.0M
$35.3M
Q3 25
$67.6M
$36.5M
Q2 25
$65.2M
$41.3M
Q1 25
$62.8M
$28.6M
Q4 24
$64.9M
$24.0M
Q3 24
$52.2M
$27.5M
Q2 24
$48.6M
$32.4M
Q1 24
$46.8M
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCI
CHCI
TLSI
TLSI
Operating Cash FlowLast quarter
$4.8M
$-2.5M
Free Cash FlowOCF − Capex
$-2.5M
FCF MarginFCF / Revenue
-19.1%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
0.36×
TTM Free Cash FlowTrailing 4 quarters
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCI
CHCI
TLSI
TLSI
Q4 25
$4.8M
$-2.5M
Q3 25
$-3.2M
$-3.7M
Q2 25
$2.2M
$-7.3M
Q1 25
$582.0K
$-4.5M
Q4 24
$10.7M
$-5.7M
Q3 24
$3.9M
$-10.8M
Q2 24
$1.3M
$-13.4M
Q1 24
$-2.2M
$-10.9M
Free Cash Flow
CHCI
CHCI
TLSI
TLSI
Q4 25
$-2.5M
Q3 25
$-3.9M
Q2 25
$-7.4M
Q1 25
$-5.3M
Q4 24
$-5.8M
Q3 24
$-11.0M
Q2 24
$-13.5M
Q1 24
$-10.9M
FCF Margin
CHCI
CHCI
TLSI
TLSI
Q4 25
-19.1%
Q3 25
-33.9%
Q2 25
-66.1%
Q1 25
-57.3%
Q4 24
-69.7%
Q3 24
-149.9%
Q2 24
-183.1%
Q1 24
-169.3%
Capex Intensity
CHCI
CHCI
TLSI
TLSI
Q4 25
0.3%
Q3 25
1.9%
Q2 25
0.8%
Q1 25
8.2%
Q4 24
0.6%
Q3 24
2.3%
Q2 24
0.8%
Q1 24
1.0%
Cash Conversion
CHCI
CHCI
TLSI
TLSI
Q4 25
0.36×
Q3 25
-5.96×
Q2 25
1.51×
Q1 25
0.37×
Q4 24
1.03×
Q3 24
1.63×
Q2 24
1.35×
Q1 24
-2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHCI
CHCI

Related Party$22.1M92%
Nonrelated Party$1.9M8%

TLSI
TLSI

Segment breakdown not available.

Related Comparisons